Stemline Therapeutics (STML) Misses Q2 EPS by 17c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/10/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP
6. TMUS
7. SPY
8. CVS
9. UNH
10. DAL

Go back to Stemline Therapeutics (STML) Misses Q2 EPS by 17c

Stemline Therapeutics Reports Second Quarter 2015 Financial Results

August 10, 2015 4:00 PM EDT

NEW YORK, Aug. 10, 2015 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML), a clinical stage biopharmaceutical company developing novel oncology drugs that primarily target cancer stem cells (CSCs) and tumor bulk, today reported financial results for the quarter ended June 30, 2015.

Ivan Bergstein, M.D., Stemline's Chief Executive Officer, commented, "This quarter, we began enrollment in the expansion stage of our SL-401 pivotal trial in BPDCN, a highly aggressive malignancy of unmet medical need. This follows completion of the lead-in stage of this trial, wherein we evaluated multiple cycle SL-401 administration at escalating doses in... More

Stemline Therapeutics Reports Second Quarter 2015 Financial Results

August 10, 2015 4:00 PM EDT

NEW YORK, Aug. 10, 2015 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML), a clinical stage biopharmaceutical company developing novel oncology drugs that primarily target cancer stem cells (CSCs) and tumor bulk, today reported financial results for the quarter ended June 30, 2015.

Ivan Bergstein, M.D., Stemline's Chief Executive Officer, commented, "This quarter, we began enrollment in the expansion stage of our SL-401 pivotal trial in BPDCN, a highly aggressive malignancy of unmet medical need. This follows completion of the lead-in stage of this trial, wherein we evaluated multiple cycle SL-401 administration at escalating doses in... More

Stemline Therapeutics to Present at the 2015 Wedbush PacGrow Healthcare Conference

August 6, 2015 8:00 AM EDT

NEW YORK, Aug. 6, 2015 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML) announced today that Ivan Bergstein, M.D., Stemline's CEO, will present at the Wedbush PacGrow Healthcare Conference on Wednesday, August 12, 2015 at 2:30 PM ET. The conference will be held at the Le Parker Meridien Hotel in New York, NY. A live webcast of the presentation can be viewed on the company's website at www.stemline.com.

About Stemline Therapeutics

Stemline... More